[PR Newswire] - SEATTLE, May 20, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that Germany's Federal Joint Committee (G-BA) has issued its final benefit assessment report for ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment